Skip to main content

Advertisement

SpringerLink
Log in

Comparing Subsidized Access to Medicines Across Payer Systems

  • Correspondence
  • Published:
PharmacoEconomics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Ragupathy R, Aaltonen K, Tordoff J, Norris P, Reith D. A 3-dimensional view of access to licensed and subsidized medicines under single-payer systems in the US, the UK, Australia and New Zealand. Pharmacoeconomics. 2012;30(11):1051–65.

    Article  PubMed  Google Scholar 

  2. Wonder M, Milne R. Access to new medicines in New Zealand compared to Australia. N Z Med J. 2011;124(1346):12–28.

    PubMed  Google Scholar 

  3. Cohen J, Cairns C, Paquette C, Faden L. Comparing patient access to pharmaceuticals in the UK and US. Appl Health Econ Health Policy. 2006;5(3):177–87.

    Article  PubMed  Google Scholar 

  4. Wilson A, Cohen J. Patient access to new cancer drugs in the United States and Australia. Value Health. 2011;14(6):944–52.

    Article  PubMed  Google Scholar 

  5. Wonder M. Patient access to new cancer drugs in the United States and Australia (letter). Value Health. 2012;15(2):397–8.

    Article  PubMed  Google Scholar 

  6. Mason A, Drummond M, Ramsey S, Campbell J, Raisch D. Comparison of anticancer drug coverage decisions in the United States and United Kingdom: does the evidence support the rhetoric? J Clin Oncol. 2010;28(20):3234–8.

    Article  PubMed  Google Scholar 

  7. Department of Health and Ageing. National immunisation program schedule. Canberra: Australian Government; 2012. http://www.immunise.health.gov.au/internet/immunise/publishing.nsf/Content/nips2. Accessed 19 Oct 2012.

  8. New Zealand Ministry of Health. National immunisation register. Wellington: New Zealand Government; 2012. http://www.health.govt.nz/our-work/preventative-health-wellness/immunisation/national-immunisation-register. Accessed 20 Oct 2012.

Download references

Acknowledgments

No funding was received for this letter and no other individual or organization was involved. The authors have no conflicts of interest.

Author information

Authors and Affiliations

  1. Wonder Drug Consulting, PO Box 470, Cronulla, NSW, 2230, Australia

    Michael Wonder

  2. Health Outcomes Associates, Auckland, New Zealand

    Richard Milne

  3. School of Population Health, University of Auckland, Auckland, New Zealand

    Richard Milne

Authors
  1. Michael Wonder
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Richard Milne
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael Wonder.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wonder, M., Milne, R. Comparing Subsidized Access to Medicines Across Payer Systems. PharmacoEconomics 31, 173–174 (2013). https://doi.org/10.1007/s40273-012-0010-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40273-012-0010-9

Keywords

Search

Navigation